Abstract: A mixed reality system that includes a device and a base station that communicate via a wireless connection The device may include sensors that collect information about the user's environment and about the user. The information collected by the sensors may be transmitted to the base station via the wireless connection. The base station renders frames or slices based at least in part on the sensor information received from the device, encodes the frames or slices, and transmits the compressed frames or slices to the device for decoding and display. The base station may provide more computing power than conventional stand-alone systems, and the wireless connection does not tether the device to the base station as in conventional tethered systems. The system may implement methods and apparatus to maintain a target frame rate through the wireless link and to minimize latency in frame rendering, transmittal, and display.

Abstract: A device identification apparatus, applicable to a first network device, the device identification apparatus includes: a receiver configured to receive first information transmitted by a first device, wherein, the first information is used to indicate that the first device is a Network-Controlled repeater or is used to determine that the first device connects to a network as a Network-Controlled repeater, or, the first information is repeater-specific first information.

Abstract: A network integration apparatus for a node, configured in a first node, includes: a mobile termination module (MT) configured to control a forward module (Fwd) of the first node; and the Fwd configured to forward a signal between a network device and a terminal equipment; wherein the MT accesses to the network as a terminal equipment via an RRC (Radio Resource Control) connection management procedure, reports information indicating the type of the first node to the network device, and performs authorization with a core network via the network device, and the Fwd is started to serve user equipment(s).

Abstract: An access control apparatus, applicable to a repeater, includes: a receiver configured to receive SIB1 transmitted by a network device, the SIB1 including an access control parameter, and processor circuitry configured to control to not apply to a unified access control procedure which is performed by using the access control parameter.

Abstract: The present invention relates to a composition for preventing or treating inflammatory or autoimmune skin disease. The composition of the present invention may be useful as a fundamental therapeutic composition that is able to efficiently ameliorate skin tissue damage caused by inflammation while having a minimized impact on systemic immune activity by specifically inhibiting the activity of skin-specific T cells. The present invention also provides a screening method capable of quickly and highly reliably identifying promising therapeutic candidates that are able to alleviate various autoimmune and inflammatory damages occurring in skin tissue by inhibiting the activity of skin-specific T cells.

Abstract: An apparatus for configuring a node, configured in a first node, includes: a mobile termination module (MT) configured to configure a forward module (Fwd) of the apparatus via a signaling procedure between the MT and a network device; and the Fwd configured to forward a signal between a terminal equipment and the network device.

Abstract: An information transmitting apparatus, applicable to a repeater, includes: a receiver configured to receive a first forwarding signal and/or a second forwarding signal; and a transmitter configured to transmit the first forwarding signal at first transmit power and/or a first amplification gain, and/or transmit the second forwarding signal at second transmit power and/or a second amplification gain.

Abstract: Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.

Abstract: A video processing method, apparatus, and device and a storage medium are provided. The method includes: monitoring an operation indication inputted by a user through a personal homepage on a social platform, the personal homepage being used for displaying personal information of the user; obtaining, when the operation indication is a shooting indication for shooting a personal status video, the personal status video; uploading the personal status video to a back-end server of the social platform; and displaying indication information of the personal status video in a personal-information display region of the personal homepage.

Abstract: The present invention pertains to the field of oilfield stimulation technologies for oil and gas field development, in particular to an instant soluble temperature and salt resistant polyacrylamide and the preparation method and application thereof, and the polyacrylamide is modified by adding rigid temperature and salt resistant monomer containing benzene ring and cationic fluorinated hydrophobic monomer on the basis of acrylamide monomer and sodium acrylate monomer, and then polymerized to obtain instant soluble temperature and salt resistant polyacrylamide. The temperature and salt resistant monomer containing benzene ring can improve the thermal stability and temperature and salt resistance of polyacrylamide, while the long-chain cationic fluorinated hydrophobic monomer can enhance the hydrophobicity of polymer. The comprehensive properties of polymer is improved by appropriate intermolecular association.

Abstract: The present invention relates to a composition for prevention or treatment of inflammatory or autoimmune skin diseases. The composition of the present invention may be useful as a fundamental therapeutic composition that is able to efficiently ameliorate skin tissue damage caused by inflammation while having a minimized impact on systemic immune activity by specifically inhibiting the activity of skin-specific T cells. In addition, the composition of the present invention may be efficiently delivered to the stratum corneum of the skin, so that it is able to exert a lesion-specific and intensive immune control effect as a composition for topical application to the skin. Moreover, it shows little toxicity to normal skin tissue, and thus is suitable even for long-term administration for the treatment of atopic dermatitis, a chronic disease.

Abstract: Provided are techniques for building and using a sparse Time Series Database (TSDB). Time series records are received from a native TSDB, where each of the time series records includes a timestamp and one or more tags. Timeslots are determined for shards for the sparse TSDB based on the timestamp included in each of the time series records. The sparse TSDB is built by creating the shards for the determined timeslots and storing the time series records in the shards, while filling in empty ranges in the shards. A query that specifies at least one of the one or more tags is received. It is determined whether to execute the query against the sparse TSDB, and, in response to a determination to execute the query against the sparse TSDB, the query is executed against the sparse TSDB to generate results that are returned.

Abstract: An IN delivery gas-phase impermeable device for delivery between 0.2 mL and 1.0 mL of a medication solution is disclosed. The device includes an injector barrel including a plurality of slit openings disposed circumferentially along the injector barrel, a center guide positioned lengthwise within the injector barrel, a cannula in fluid communication with the medication solution fixed in position by the center guide, and a vial configured to couple with the injector barrel. The vial includes a pliable rubber stopper with multiple seal rings, each seal ring having a geometry configured to form a gas-phase impermeable seal with an internal surface of the vial. The cannula bisects the pliable rubber stopper. The device includes a base configured to reversibly engage with one or more of the slit openings of the injector barrel during actuation of the device, which may involve compression of the base toward the injector barrel.

Abstract: Disclosed is a preparation method for triphenylchloromethane, comprising the following steps: adding hydrochloric acid or a mixture of hydrochloric acid and Lewis acid to a mixture of triphenylmethanol and an organic solvent; stirring for reaction; removing the water layer after the completion of reaction to obtain an organic solution containing triphenylchloromethane. In the method, the conversion rate of triphenylmethanol is almost quantitative to be above 99%, and the content of triphenylchloromethane in the product obtained is above 99%. The operation is simple, and no waste gas is generated. Therefore, the method is environmentally friendly and suitable for industrialized production and can achieve better economic benefits.

Abstract: A signal transmitting apparatus, configured in a repeater, includes: communication processor circuitry configured to transmit a first signal; and forwarding processor circuitry configured to transmit a second signal, wherein, the forwarding processor circuitry does not transmit over a time resource if the communication processor circuitry transmits over the time resource.

Abstract: A method for delivering a medication for treatment of a pulmonary disease depending on location(s) of infection lesion(s) within a respiratory tract of a patient is disclosed. The method includes administering metered doses of the medication to the patient having the pulmonary disease by a metered dose inhaler (MDI) actuator having a function of controlling drug particle delivery characteristics. The medication is effective for treating the pulmonary disease. A therapeutically effective amount of medication for treating the pulmonary disease is administered by various metered doses of the medication. The medication includes an active pharmaceutical ingredient (API) associated with treatment of a pulmonary disease. The medication includes a propellant, a co-solvent, and a surfactant. The API is dissolved in the propellant at a pre-determined ratio, with or without a co-solvent. The medication is administered via metered-dose inhalation.

Abstract: A mixed reality system that includes a device and a base station that communicate via a wireless connection The device may include sensors that collect information about the user's environment and about the user. The information collected by the sensors may be transmitted to the base station via the wireless connection. The base station renders frames or slices based at least in part on the sensor information received from the device, encodes the frames or slices, and transmits the compressed frames or slices to the device for decoding and display. The base station may provide more computing power than conventional stand-alone systems, and the wireless connection does not tether the device to the base station as in conventional tethered systems. The system may implement methods and apparatus to maintain a target frame rate through the wireless link and to minimize latency in frame rendering, transmittal, and display.

Abstract: An off-road electric motorcycle includes a frame; wheels including at least a front wheel and a rear wheel; a power system including an electric motor and a battery pack, where the electric motor is used for driving the wheels, and the battery pack is used for supplying power to the electric motor; and a braking system including at least a braking device for braking a vehicle. The frame includes a support assembly disposed along a length direction of the electric motorcycle. The support assembly is divided into at least a first installation section and a second installation section. The battery pack is pluggably mounted in the first installation section, and the first installation section is located at the front end of the second installation section.

Abstract: This disclosure relates to curable silicone rubber compositions suitable for use in the manufacture of cured-in-place gaskets (CIPGs), silicone elastomers resulting from the cure of such compositions and methods for making CIPGs from such compositions. The inclusion of a compound having at least two trialkoxysilyl groups, at least two dialkoxyalkylsilyl groups or a mixture of two or more trialkoxysilyl groups, and dialkoxyalkylsilyl groups per molecule selected from: (i) (R10)z (R11)3-z Si—(W)—Si (R11)3-z (R10)z; or (ii) 1,3,5-tris[3-((R10)z(R11)3-z Si)-D]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione where each R11 is independently an alkoxy group having 1 to 6 carbons; each R10 is independently R11 or an alkyl group having 1 to 6 carbons, z is 0 or 1; W is a linear or branched alkylene having 1 to 12 carbons; and D is an alkylene group having from 1 to 6 carbons; provides CIPGs which show both a good adhesion to aluminium and a good compression set.

Abstract: A device for reporting power-related information, applicable to a first network node, the first network node comprising a first module and a second module, includes: reporting processor circuitry provided in the first module of the first network node and configured to report power-related information of the second module.